More younger adults are being screened for and diagnosed with colon cancer, according to studies published on Aug. 4.
Smaller increases for other age ranges—1.6 percent annually for adults aged 20 to 39 since 2004, 2 percent annually for adults aged 40 to 44 since 2012, and 2.6 percent for adults aged 50 to 54 since 2012—were also recorded.
Elizabeth Schafer, with the American Cancer Society’s Surveillance and Health Equity Science Department, and co-authors with the society said the sharper jump among adults aged 45 to 49 “likely reflects diagnosis of prevalent asymptomatic cancer through first-time screening due to recommendations for adults to begin screening at age 45 years instead of 50 years.”
The society in 2018 advised starting screening for colon cancer, also known as colorectal cancer, at age 45. The U.S. Preventive Services Task Force issued the same recommendation in 2021.
The study, published by the Journal of the American Medical Association, analyzed data from 21 different registries from the government-supported Surveillance, Epidemiology, and End Results program, which collects data on cancer incidence and survival rates.
Researchers listed no conflicts of interest. They said the study’s limitations included potential influence from the COVID-19 pandemic.
They also found that screening remained about the same for other age groups.
Among the limitations of that paper, for which no conflicts of interest were reported, were potentially inaccurate recall and possible overestimation.
The researchers completed a randomized clinical trial with about 20,500 adults to test which one yielded the highest percentage of screenings. The three non-mailer strategies utilized messages with different focuses, conveyed through a patient portal.
The researchers advised future researchers to look at how to best tailor prepaid mailers to boost screening numbers.
Conflicts of interest included grants from the National Science Foundation. The trial was run out of a single center, and researchers did not assess the cost-effectiveness of the mailers, which cost $8 each.







